May 25, 2024
Lloyd Price

Health Tech founder and M&A Advisor Lloyd Price shares his thoughts with Pharmaceutical Market Europe about Clinical Trials and Diversity challenges.

“Price sees a well of digital approaches that could energise trial enrolment among under-represented communities and boost retention.

But he cautions: “It’s important to remember that technology is a tool, and its success hinges on its implementation alongside culturally sensitive practices and a genuine commitment to diversity within the research community.

By making trials more accessible, culturally sensitive and transparent, technology can pave the way for more inclusive research and ultimately, better healthcare outcomes for everyone.

‘Results from a poll of 2,000 people reveal respondents have significant trust in vaccines and prescription drugs but less trust in...

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Clinical Trials, Pharma, Pharma / Biotech, Trends
Labcorp launches suite of laboratory solutions designed to expedite clinical trials
The critical role of comprehensive RNA sequencing in liquid biopsy for biomarker discovery and clinical trials
For Teens With Severe Obesity, Financial Incentives Work for Weight Loss
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Walgreens executive says it is ‘doubling down’ on recruiting customers into clinical trials

Share This Article